Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

COHN vs IIIV vs TYRA vs GAIN vs HTGC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
COHN
Cohen & Company Inc.

Financial - Capital Markets

Financial ServicesAMEX • US
Market Cap$87M
5Y Perf.-26.4%
IIIV
i3 Verticals, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$506M
5Y Perf.-5.4%
TYRA
Tyra Biosciences, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.77B
5Y Perf.+87.0%
GAIN
Gladstone Investment Corporation

Asset Management

Financial ServicesNASDAQ • US
Market Cap$657M
5Y Perf.+19.0%
HTGC
Hercules Capital, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$3.07B
5Y Perf.-1.3%

COHN vs IIIV vs TYRA vs GAIN vs HTGC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
COHN logoCOHN
IIIV logoIIIV
TYRA logoTYRA
GAIN logoGAIN
HTGC logoHTGC
IndustryFinancial - Capital MarketsSoftware - InfrastructureBiotechnologyAsset ManagementAsset Management
Market Cap$87M$506M$1.77B$657M$3.07B
Revenue (TTM)$278M$223M$0.00$90M$547M
Net Income (TTM)$14M$16M$-120M$130M$289M
Gross Margin93.8%60.4%68.6%87.2%
Operating Margin22.3%0.8%72.7%66.7%
Forward P/E3.3x20.3x40.7x8.4x
Total Debt$450M$8M$6M$456M$2.30B
Cash & Equiv.$57M$67M$77M$14M$57M

COHN vs IIIV vs TYRA vs GAIN vs HTGCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

COHN
IIIV
TYRA
GAIN
HTGC
StockSep 21May 26Return
Cohen & Company Inc. (COHN)10073.6-26.4%
i3 Verticals, Inc. (IIIV)10094.6-5.4%
Tyra Biosciences, I… (TYRA)100187.0+87.0%
Gladstone Investmen… (GAIN)100119.0+19.0%
Hercules Capital, I… (HTGC)10098.7-1.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: COHN vs IIIV vs TYRA vs GAIN vs HTGC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: COHN leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Gladstone Investment Corporation is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. TYRA also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
COHN
Cohen & Company Inc.
The Banking Pick

COHN carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 249.6%, EPS growth 55.4%
  • Lower volatility, beta 0.48, current ratio 3.87x
  • 249.6% NII/revenue growth vs TYRA's -38.9%
  • Lower P/E (3.3x vs 8.4x)
Best for: growth exposure and sleep-well-at-night
IIIV
i3 Verticals, Inc.
The Technology Pick

IIIV lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
TYRA
Tyra Biosciences, Inc.
The Momentum Pick

TYRA ranks third and is worth considering specifically for momentum.

  • +260.4% vs IIIV's -13.8%
Best for: momentum
GAIN
Gladstone Investment Corporation
The Banking Pick

GAIN is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 0 yrs, beta 0.53, yield 10.0%
  • 319.3% 10Y total return vs HTGC's 171.6%
  • Beta 0.53, yield 10.0%, current ratio 3.69x
  • 72.7% margin vs COHN's 5.2%
Best for: income & stability and long-term compounding
HTGC
Hercules Capital, Inc.
The Banking Pick

HTGC is the clearest fit if your priority is bank quality.

  • NIM 9.1% vs GAIN's 5.5%
Best for: bank quality
See the full category breakdown
CategoryWinnerWhy
GrowthCOHN logoCOHN249.6% NII/revenue growth vs TYRA's -38.9%
ValueCOHN logoCOHNLower P/E (3.3x vs 8.4x)
Quality / MarginsGAIN logoGAIN72.7% margin vs COHN's 5.2%
Stability / SafetyCOHN logoCOHNBeta 0.48 vs IIIV's 0.92
DividendsCOHN logoCOHN2.5% yield, 1-year raise streak, vs GAIN's 10.0%, (2 stocks pay no dividend)
Momentum (1Y)TYRA logoTYRA+260.4% vs IIIV's -13.8%
Efficiency (ROA)GAIN logoGAIN10.5% ROA vs TYRA's -38.4%, ROIC 5.3% vs -44.8%

COHN vs IIIV vs TYRA vs GAIN vs HTGC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

COHNCohen & Company Inc.
FY 2025
New Issue and Advisory
82.5%$308M
Underwriting
16.5%$62M
Origination
1.0%$4M
IIIVi3 Verticals, Inc.
FY 2025
License and Service
93.7%$149M
Other Revenue
6.3%$10M
TYRATyra Biosciences, Inc.

Segment breakdown not available.

GAINGladstone Investment Corporation

Segment breakdown not available.

HTGCHercules Capital, Inc.

Segment breakdown not available.

COHN vs IIIV vs TYRA vs GAIN vs HTGC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCOHNLAGGINGHTGC

Income & Cash Flow (Last 12 Months)

GAIN leads this category, winning 3 of 5 comparable metrics.

HTGC and TYRA operate at a comparable scale, with $547M and $0 in trailing revenue. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to COHN's 5.2%.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
RevenueTrailing 12 months$278M$223M$0$90M$547M
EBITDAEarnings before interest/tax$63M$31M-$132M$58M$381M
Net IncomeAfter-tax profit$14M$16M-$120M$130M$289M
Free Cash FlowCash after capex$26M$10M-$95M-$82M-$352M
Gross MarginGross profit ÷ Revenue+93.8%+60.4%+68.6%+87.2%
Operating MarginEBIT ÷ Revenue+22.3%+0.8%+72.7%+66.7%
Net MarginNet income ÷ Revenue+5.2%+7.3%+72.7%+62.1%
FCF MarginFCF ÷ Revenue+9.4%+4.7%+126.8%-77.8%
Rev. Growth (YoY)Latest quarter vs prior year-14.6%
EPS Growth (YoY)Latest quarter vs prior year+5.4%-78.0%-32.6%+58.1%-20.7%
GAIN leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

COHN leads this category, winning 4 of 6 comparable metrics.

At 3.3x trailing earnings, COHN trades at a 92% valuation discount to IIIV's 40.9x P/E. On an enterprise value basis, COHN's 7.6x EV/EBITDA is more attractive than GAIN's 16.8x.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
Market CapShares × price$87M$506M$1.8B$657M$3.1B
Enterprise ValueMkt cap + debt − cash$481M$447M$1.7B$1.1B$5.3B
Trailing P/EPrice ÷ TTM EPS3.27x40.91x-16.37x9.28x8.86x
Forward P/EPrice ÷ next-FY EPS est.20.30x40.66x8.41x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.65x14.02x16.82x14.54x
Price / SalesMarket cap ÷ Revenue0.31x2.37x7.31x5.61x
Price / BookPrice ÷ Book value/share0.82x1.51x7.57x1.22x1.44x
Price / FCFMarket cap ÷ FCF3.34x134.87x5.77x
COHN leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

COHN leads this category, winning 3 of 9 comparable metrics.

GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-41 for TYRA. IIIV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHN's 4.37x. On the Piotroski fundamental quality scale (0–9), COHN scores 6/9 vs TYRA's 1/9, reflecting solid financial health.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
ROE (TTM)Return on equity+15.1%+3.2%-41.2%+21.9%+13.2%
ROA (TTM)Return on assets+1.6%+2.6%-38.4%+10.5%+6.4%
ROICReturn on invested capital+12.2%+0.6%-44.8%+5.3%+6.6%
ROCEReturn on capital employed+7.6%+0.7%-43.3%+6.8%+8.8%
Piotroski ScoreFundamental quality 0–965145
Debt / EquityFinancial leverage4.37x0.01x0.02x0.91x1.04x
Net DebtTotal debt minus cash$393M-$59M-$72M$441M$2.2B
Cash & Equiv.Liquid assets$57M$67M$77M$14M$57M
Total DebtShort + long-term debt$450M$8M$6M$456M$2.3B
Interest CoverageEBIT ÷ Interest expense8.32x5.21x1.58x4.34x
COHN leads this category, winning 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — COHN and TYRA and GAIN each lead in 2 of 6 comparable metrics.

A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $6,442 for COHN. Over the past 12 months, TYRA leads with a +260.4% total return vs IIIV's -13.8%. The 3-year compound annual growth rate (CAGR) favors COHN at 45.3% vs IIIV's -0.8% — a key indicator of consistent wealth creation.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
YTD ReturnYear-to-date-31.3%-9.3%+22.8%+20.7%-10.6%
1-Year ReturnPast 12 months+106.3%-13.8%+260.4%+30.8%+6.6%
3-Year ReturnCumulative with dividends+206.8%-2.5%+143.7%+56.5%+63.9%
5-Year ReturnCumulative with dividends-35.6%-27.6%+26.5%+72.0%+46.8%
10-Year ReturnCumulative with dividends+156.3%+24.9%+26.5%+319.3%+171.6%
CAGR (3Y)Annualised 3-year return+45.3%-0.8%+34.6%+16.1%+17.9%
Evenly matched — COHN and TYRA and GAIN each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.

COHN is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than IIIV's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 96.3% from its 52-week high vs COHN's 43.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
Beta (5Y)Sensitivity to S&P 5000.48x0.92x0.75x0.53x0.69x
52-Week HighHighest price in past year$32.60$33.97$40.65$17.14$19.67
52-Week LowLowest price in past year$7.78$19.89$8.75$13.11$13.70
% of 52W HighCurrent price vs 52-week peak+43.6%+67.4%+80.9%+96.3%+83.4%
RSI (14)Momentum oscillator 0–10031.047.843.169.964.7
Avg Volume (50D)Average daily shares traded28K292K1.1M371K2.5M
Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.

Analyst consensus: IIIV as "Buy", TYRA as "Buy", GAIN as "Hold", HTGC as "Buy". Consensus price targets imply 53.5% upside for TYRA (target: $51) vs -9.1% for GAIN (target: $15). For income investors, GAIN offers the higher dividend yield at 10.05% vs COHN's 2.51%.

MetricCOHN logoCOHNCohen & Company I…IIIV logoIIIVi3 Verticals, Inc.TYRA logoTYRATyra Biosciences,…GAIN logoGAINGladstone Investm…HTGC logoHTGCHercules Capital,…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$29.00$50.50$15.00$18.92
# AnalystsCovering analysts147731
Dividend YieldAnnual dividend ÷ price+2.5%+10.0%+8.6%
Dividend StreakConsecutive years of raises100
Dividend / ShareAnnual DPS$0.36$1.66$1.42
Buyback YieldShare repurchases ÷ mkt cap0.0%+7.4%0.0%0.0%+0.2%
Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.
Key Takeaway

COHN leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). GAIN leads in 1 (Income & Cash Flow). 3 tied.

Best OverallCohen & Company Inc. (COHN)Leads 2 of 6 categories
Loading custom metrics...

COHN vs IIIV vs TYRA vs GAIN vs HTGC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is COHN or IIIV or TYRA or GAIN or HTGC a better buy right now?

For growth investors, Cohen & Company Inc.

(COHN) is the stronger pick with 249. 6% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Cohen & Company Inc. (COHN) offers the better valuation at 3. 3x trailing P/E, making it the more compelling value choice. Analysts rate i3 Verticals, Inc. (IIIV) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — COHN or IIIV or TYRA or GAIN or HTGC?

On trailing P/E, Cohen & Company Inc.

(COHN) is the cheapest at 3. 3x versus i3 Verticals, Inc. at 40. 9x. On forward P/E, Hercules Capital, Inc. is actually cheaper at 8. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — COHN or IIIV or TYRA or GAIN or HTGC?

Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.

0%, compared to -35. 6% for Cohen & Company Inc. (COHN). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus IIIV's +24. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — COHN or IIIV or TYRA or GAIN or HTGC?

By beta (market sensitivity over 5 years), Cohen & Company Inc.

(COHN) is the lower-risk stock at 0. 48β versus i3 Verticals, Inc. 's 0. 92β — meaning IIIV is approximately 92% more volatile than COHN relative to the S&P 500. On balance sheet safety, i3 Verticals, Inc. (IIIV) carries a lower debt/equity ratio of 1% versus 4% for Cohen & Company Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — COHN or IIIV or TYRA or GAIN or HTGC?

By revenue growth (latest reported year), Cohen & Company Inc.

(COHN) is pulling ahead at 249. 6% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Cohen & Company Inc. grew EPS 55. 4% year-over-year, compared to -87. 9% for i3 Verticals, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — COHN or IIIV or TYRA or GAIN or HTGC?

Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.

7% net margin versus 0. 0% for Tyra Biosciences, Inc. — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 72. 7% versus 0. 0% for TYRA. At the gross margin level — before operating expenses — COHN leads at 93. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is COHN or IIIV or TYRA or GAIN or HTGC more undervalued right now?

On forward earnings alone, Hercules Capital, Inc.

(HTGC) trades at 8. 4x forward P/E versus 40. 7x for Gladstone Investment Corporation — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TYRA: 53. 5% to $50. 50.

08

Which pays a better dividend — COHN or IIIV or TYRA or GAIN or HTGC?

In this comparison, GAIN (10.

0% yield), HTGC (8. 6% yield), COHN (2. 5% yield) pay a dividend. IIIV, TYRA do not pay a meaningful dividend and should not be held primarily for income.

09

Is COHN or IIIV or TYRA or GAIN or HTGC better for a retirement portfolio?

For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, IIIV: +24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between COHN and IIIV and TYRA and GAIN and HTGC?

These companies operate in different sectors (COHN (Financial Services) and IIIV (Technology) and TYRA (Healthcare) and GAIN (Financial Services) and HTGC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: COHN is a small-cap high-growth stock; IIIV is a small-cap quality compounder stock; TYRA is a small-cap quality compounder stock; GAIN is a small-cap deep-value stock; HTGC is a small-cap high-growth stock. COHN, GAIN, HTGC pay a dividend while IIIV, TYRA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

COHN

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 124%
  • Net Margin > 5%
Run This Screen
Stocks Like

IIIV

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

TYRA

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

GAIN

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 43%
  • Dividend Yield > 4.0%
Run This Screen
Stocks Like

HTGC

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 37%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform COHN and IIIV and TYRA and GAIN and HTGC on the metrics below

Revenue Growth>
%
(COHN: 249.6% · IIIV: -14.6%)
Net Margin>
%
(COHN: 5.2% · IIIV: 7.3%)
P/E Ratio<
x
(COHN: 3.3x · IIIV: 40.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.